![]() ![]() I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. The study used (or will use) ONLY openly available human data that were originally located at the MEDLINE, Scopus, Cochrane Library, and Embase databases The details of the IRB/oversight body that provided approval or exemption for the research described are given below: I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. This study did not receive any funding Author Declarations ![]() The authors have declared no competing interest. This increased risk should be evaluated along with other important factors, such as the incidence of local outbreaks and the risk for arrhythmia due to COVID infection itself, when weighing the safety and efficacy of COVID-19 vaccines. All-cause mortality was comparable between the COVID-19 and non–COVID-19 vaccination groups.Ĭonclusions The overall risk for arrhythmia after COVID-19 vaccination was relatively low, although it was higher in COVID-19 vaccine recipients than in non–COVID-19 vaccine recipients. Arrhythmia was also more frequent after the third dose of COVID-19 vaccine (19,064.3 cases per million doses 7968 doses, 3 studies) than after the first dose (3450.9 cases per million doses 41,714,762 doses, 12 studies P=0.05) or second dose (2262.5 cases per million doses 34,540,749 doses, 10 studies P<0.01). The incidence of tachyarrhythmia was significantly higher after COVID-19 vaccination (4367.5 cases per million doses 1,208,656 doses, 15 studies) than after non– COVID-19 vaccination (25.8 cases per million doses 179,822,553 doses, 11 studies P<0.01). Compared with COVID-19 vaccines, the influenza, pertussis, human papillomavirus, and acellular pertussis vaccines were associated with a significantly lower incidence of arrhythmia. The incidence of arrhythmia was significantly higher after COVID-19 vaccination (2263.4 cases per million doses 830,585,553 doses, 23 studies) than after non–COVID-19 vaccination (9.9 cases per million doses 697,874,109 doses, 14 studies P<0.01). They can help you make an informed decision for your specific situation.Results The overall incidence of arrhythmia from 36 studies (1,528,459,662 vaccine doses) was 291.8 (95% CI 111.6-762.7) cases per million doses. Talk to your healthcare provider about the potential benefits and risks of receiving an RSV vaccine. It isn’t clear if the early births happened because of the vaccine, or other reasons. During clinical trials, a small increase in preterm births were observed in pregnant women who got Abrysvo. This is when your baby is born before 37 weeks of pregnancy. Get immediate medical attention if these develop.Īnother possible complication that could happen after getting an RSV vaccine during pregnancy is preterm birth. Symptoms can include persistent or severe headaches, vision changes, or swelling in your face or hands. Preeclampsia usually happens around the last month of pregnancy, which is when you would receive Abrysvo. But the rate of preeclampsia was slightly higher in the Abrysvo group. Some pregnant women, including those who received Abrysvo and those who did not, developed preeclampsia. Preeclampsia is a condition during pregnancy that causes dangerously high blood pressure. Are there potential risks for pregnant women? ![]() Get medical help right away if you notice any of these symptoms.Ī few other rare, but serious side effects reported after vaccination include atrial fibrillation (abnormal heart rhythm) and a rare type of brain and spinal cord inflammation. The risk of this happening is low, but watch out for signs such as rash, swelling in your face or throat, and trouble breathing. Severe allergic reactions (anaphylaxis) are possible with any vaccine. Symptoms of GBS include muscle weakness, a “pins and needles” feeling, and problems with balance. More research is needed to know if the risk of GBS is higher after getting an RSV vaccine. With both Abrysvo and Arexvy, there were a few reports of a serious neurologic condition called Guillain-Barré syndrome (GBS). While it’s not clear if they were actually caused by the vaccine, it’s important to be aware of them. Some people who received an RSV vaccine during clinical trials experienced serious side effects, although this was very rare.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |